Taking another step in its evolving strategy to gain a foothold in the next-generation DNA sequencing market, Applied Biosystems has inked a deal to acquire Agencourt Personal Genomics for approximately $120 million in cash.

The acquisition provides ABI with a relatively advanced technology in the emerging market for alternative DNA sequencing instruments, and the firm said it expects to place initial systems with early-access customers in 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.